New Year, New Model Portfolio Addition (Biotech Select $)
Establishing a position in this beaten-down stock, as there is potential to be found in one of its experimental drugs.
07:55AM 12/31/08
Feuerstein's Biotech-Stock Mailbag
Vertex's cystic fibrosis compound shows promise, but be cautious in your enthusiasm. Also, an update on the quest for blood substitutes.
12:01PM 03/29/08
Feuerstein's Biotech-Stock Mailbag
Feuerstein backs his bearish stance on Cell Genesys' prostate cancer vaccine.
10:01AM 03/01/08
Feuerstein's Biotech-Stock Mailbag
Cell Genesys' 'news' this week doesn't do much to boost prospects for its prostate cancer vaccine.
10:41AM 02/23/08
Wednesday's Health Winners & Losers
Encysive shines in an otherwise down day for the sector.
04:42PM 02/20/08
TheStreet.com Smart!Market Report: Financials, H-P Send Stocks Higher
Oil resumes its rally and is above $100 a barrel.
04:37PM 02/20/08
Pfizer agrees to buy the troubled blood pressure drug maker for $195 million.
01:16PM 02/20/08
The Mile High City is more than a gateway to winter sports. Here's how to make the most of your stay.
10:39AM 01/10/08
Health Care's 10 Dumbest Things, Part Two
WellCare and Encysive were among this year's big losers.
06:19AM 12/31/07
Feuerstein's 2007 Biotech-Stock Report Card
This year's calls brought more hits than misses.
11:26AM 12/22/07
Feuerstein's Biotech-Stock Mailbag
FDA is unlikely to reverse its earlier decision on Provenge.
10:55AM 12/15/07
Feuerstein's Biotech-Stock Mailbag
This week, updates on Dendreon and Medarex.
11:54AM 09/29/07
How Beat the Street Winner Learned the Game
Jim Cramer congratulates Beat the Street Winner Becky Smith and learns how she got into trading.
04:07PM 09/11/07
The company continues to look like large-cap biotech's best bet.
12:21PM 09/11/07



Connect with TheStreet